Multaq Linked to Severe Liver Failure
The FDA has issued an alert concerning the use of the drug dronedarone, sold under the brand name Multaq. This FDA Multaq warning comes after receiving reports of liver failure in several patients taking the drug . Multaq is a treatment for patients who are at increased risk of heart attacks because of conditions such as diabetes or high blood pressure. Since dronedarone's approval in 2009 about 492,000 dronedarone prescriptions have been written world wide with 147,000 patients filled dronedarone prescriptions in the US according to the FDA. The dronedarone warning of its link to liver failure is bad news for a drug that was originally thought to be a blockbuster due to the Multag side effects.
Dronedarone (Multaq), which was a highly publicized drug targeted at atrial fibrillation and sold under the brand name Multaq, appears to only be half as effective as the generic drug amiodarone and has more side. It was recommended for use only as a second- or third-line drug if all others fail. But now with the new FDA Multaq warning of possible dronedarone liver failure, that will have to be reexamined. Atrial fibrillation, is a rapid and irregular beat in the upper chambers of the heart and affects over 2 million people in the U.S., according to the National Heart, Lung and Blood Institute.
Common of Multaq Side Effects
In addition to possible Multaq liver failure other side effects include:
Symptoms of Multaq Liver failure may Include:
All Patients taking Multaq and concerned about the Multaq warning are advised to contact their Doctors about any concerns relating to Multaq side effects, but the drug should not be stopped unless under a doctor’s direction.
You May be entitled to Compensation, so act now.
If you or a loved one has been injured as a result of taking Multaq or want to find out more about the Multaq warning and have experienced liver problems contact us now to speak with our qualified professionals about possible compensation. Call us now at 877-222-7069 or use the contact form for a free case review.
The FDA annouced on July 6th, that Stryker has announced a voluntary recall of its modular neck...
Hip Replacement Recall Announced
DePuy Orthopaedics, a unit of Johnson & Johnson, announced the...
Innovative Surgical, the manufacture of the Da Vinci Surgery Robot recieved a warning letter from FDA...
ATTORNEY ADVERTISEMENT— The information provided on RecallWarning.com is not a substitute for professional medical or legal advice, diagnosis or treatment. In addition, viewing the content on this website, requesting additional information, or transmitting information through a contact form does not form an attorney-client relationship with the sponsoring attorney. This website is independent of the FDA or any other medical or Govenmental organization. Information on this site is intended for educational purposes only and should never interfere with a patient/site visitor and his or her healthcare provider.
RecallWarning.com is owned and operated by ProSoftLabs
Let Us Help!